These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31811079)

  • 1. A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease.
    Zhao X; Kang J; Svetnik V; Warden D; Wilcock G; David Smith A; Savage MJ; Laterza OF
    J Appl Lab Med; 2020 Jan; 5(1):15-28. PubMed ID: 31811079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment.
    Cheng L; Doecke JD; Sharples RA; Villemagne VL; Fowler CJ; Rembach A; Martins RN; Rowe CC; Macaulay SL; Masters CL; Hill AF;
    Mol Psychiatry; 2015 Oct; 20(10):1188-96. PubMed ID: 25349172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study.
    Roed L; Grave G; Lindahl T; Rian E; Horndalsveen PO; Lannfelt L; Nilsson C; Swenson F; Lönneborg A; Sharma P; Sjögren M
    J Alzheimers Dis; 2013; 35(3):611-21. PubMed ID: 23478308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach.
    Errington N; Iremonger J; Pickworth JA; Kariotis S; Rhodes CJ; Rothman AM; Condliffe R; Elliot CA; Kiely DG; Howard LS; Wharton J; Thompson AAR; Morrell NW; Wilkins MR; Wang D; Lawrie A
    EBioMedicine; 2021 Jul; 69():103444. PubMed ID: 34186489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.
    Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM
    Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A blood based 12-miRNA signature of Alzheimer disease patients.
    Leidinger P; Backes C; Deutscher S; Schmitt K; Mueller SC; Frese K; Haas J; Ruprecht K; Paul F; Stähler C; Lang CJ; Meder B; Bartfai T; Meese E; Keller A
    Genome Biol; 2013 Jul; 14(7):R78. PubMed ID: 23895045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Random forest-integrated analysis in AD and LATE brain transcriptome-wide data to identify disease-specific gene expression.
    Wu X; Peng C; Nelson PT; Cheng Q
    PLoS One; 2021; 16(9):e0256648. PubMed ID: 34492068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of AclarusDx™, a blood-based transcriptomic signature for the diagnosis of Alzheimer's disease.
    Fehlbaum-Beurdeley P; Sol O; Désiré L; Touchon J; Dantoine T; Vercelletto M; Gabelle A; Jarrige AC; Haddad R; Lemarié JC; Zhou W; Hampel H; Einstein R; Vellas B;
    J Alzheimers Dis; 2012; 32(1):169-81. PubMed ID: 22785402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
    Shi D; Han M; Liu W; Tao J; Chen L
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of advanced machine learning methods on resting-state fMRI network for identification of mild cognitive impairment and Alzheimer's disease.
    Khazaee A; Ebrahimzadeh A; Babajani-Feremi A
    Brain Imaging Behav; 2016 Sep; 10(3):799-817. PubMed ID: 26363784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment.
    Xu L; Wu X; Chen K; Yao L
    Comput Methods Programs Biomed; 2015 Nov; 122(2):182-90. PubMed ID: 26298855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature.
    Boccardi V; Paolacci L; Remondini D; Giampieri E; Poli G; Curti N; Cecchetti R; Villa A; Ruggiero C; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2019; 72(3):911-918. PubMed ID: 31658056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A candidate plasma protein classifier to identify Alzheimer's disease.
    Zhao X; Lejnine S; Spond J; Zhang C; Ramaraj TC; Holder DJ; Dai H; Weiner R; Laterza OF
    J Alzheimers Dis; 2015; 43(2):549-63. PubMed ID: 25114072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recency ratio is related to CSF amyloid beta 1-42 levels in MCI-AD.
    Bruno D; Gleason CE; Koscik RL; Pomara N; Zetterberg H; Blennow K; Johnson SC
    Int J Geriatr Psychiatry; 2019 Mar; 34(3):415-419. PubMed ID: 30430632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA -483-5p as a Potential Noninvasive Biomarker for Early Detection of Alzheimer's Disease.
    Sabry R; El Sharkawy RE; Gad NM
    Egypt J Immunol; 2020 Jun; 27(2):59-72. PubMed ID: 33548978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of patients with MCI and AD from healthy controls using directed graph measures of resting-state fMRI.
    Khazaee A; Ebrahimzadeh A; Babajani-Feremi A;
    Behav Brain Res; 2017 Mar; 322(Pt B):339-350. PubMed ID: 27345822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.